What is the recommended dose of bismuth (Bismuth subsalicylate) for the treatment of peptic ulcer disease associated with Helicobacter pylori?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bismuth Subsalicylate Dosing for H. pylori Eradication

For treatment of peptic ulcer disease associated with Helicobacter pylori, bismuth subsalicylate should be dosed at 262 mg (2 tablets) four times daily for 14 days as part of quadruple therapy with tetracycline 500 mg four times daily, metronidazole 500 mg three to four times daily, and a proton pump inhibitor twice daily. 1, 2

Standard Bismuth Quadruple Therapy Regimen

The complete regimen consists of four components taken for 14 days 1, 2:

  • Bismuth subsalicylate: 262 mg (2 tablets or 2 capsules) four times daily, taken 30 minutes before meals 1, 2
  • Tetracycline HCl: 500 mg four times daily, taken 30 minutes after meals 1, 2
  • Metronidazole: 500 mg three to four times daily (or 400 mg four times daily), taken 30 minutes after meals 1, 2
  • Proton pump inhibitor: High-dose PPI (esomeprazole 20 mg or rabeprazole 20 mg preferred) twice daily, taken 30 minutes before meals and at bedtime 1, 3

Alternative Bismuth Formulations

Some formulations use bismuth subcitrate at 120-140 mg three to four times daily, which is equivalent dosing 3, 2. The key is ensuring adequate bismuth exposure throughout the day with the four-times-daily dosing schedule 1, 2.

Duration of Treatment

All major guidelines converge on 14 days as the optimal duration 1, 2:

  • The Toronto Consensus firmly recommends 14 days for all first-line treatments to maximize eradication rates 1, 2
  • The Maastricht V/Florence Consensus agrees with 14 days unless 10 days has been proven locally to be equally effective 1, 2
  • The American College of Gastroenterology considers 10-14 days adequate, though 14 days is preferred 1, 2

The 14-day duration is particularly important in areas with high metronidazole resistance, as longer treatment can partially overcome this resistance 3, 2.

Clinical Context and Rationale

Bismuth quadruple therapy is recommended as first-line treatment in areas with high clarithromycin resistance (>15-20%) 3, 2. This regimen is favored because it achieves acceptable success even against strains displaying in vitro metronidazole resistance 1, 4. The addition of bismuth significantly improves treatment efficacy, especially when metronidazole resistance is present 3, 4.

Critical Administration Details

Timing is essential for optimal efficacy 1:

  • Take bismuth 30 minutes before meals
  • Take tetracycline and metronidazole 30 minutes after meals
  • Take PPI 30 minutes before meals on an empty stomach 2

Important Caveats

Do not substitute doxycycline for tetracycline, as multiple studies demonstrate significantly inferior results 3, 2. This is a common pitfall that must be avoided.

Avoid pantoprazole as the PPI choice 1, 3. Rabeprazole and esomeprazole are preferred due to higher potency (20 mg rabeprazole = 36 mg omeprazole; 20 mg esomeprazole = 32 mg omeprazole; 40 mg pantoprazole = only 9 mg omeprazole) 1.

The bismuth quadruple regimen is considered one of the least tolerable H. pylori therapies due to side effects including black stools, nausea, headache, and dizziness 3, 5. However, these adverse effects are generally manageable and should not prevent use of this highly effective regimen when indicated.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bismuth Quadruple Therapy for H. pylori Eradication

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Helicobacter pylori Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

H. pylori Eradication Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.